BCN Checkpoint
- Address
- Carrer del Comte Borrell 164-166, 08015 Barcelona, Spain
BCN Checkpoint - HIV Research and Treatment Innovation Center
BCN Checkpoint is a specialized clinical research facility dedicated to advancing HIV care through innovative therapeutic strategies and patient-centered treatment delivery models. The center focuses on evaluating novel antiretroviral therapies and improving treatment accessibility for individuals living with HIV infection across different stages of disease progression.
- Long-acting injectable antiretroviral therapy implementation and administration models
- Novel therapeutic strategies for recent HIV-1 infection management
- Patient acceptability and satisfaction studies for out-of-hospital HIV treatment delivery
The research center's work encompasses both early HIV infection intervention and long-term maintenance therapy optimization. BCN Checkpoint is particularly focused on evaluating the safety, tolerability, and feasibility of emerging treatment options, including long-acting cabotegravir and rilpivirine combinations and investigational therapies such as tyrosine kinase inhibitors. By comparing hospital-based versus out-of-hospital administration models, the center aims to enhance treatment convenience and improve quality of life for people living with HIV while maintaining rigorous safety standards.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 567 other sites in Spain
Therapeutic Area Benchmark — Spain
Select a therapeutic area to compare against other sites in Spain.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Spain
Market Share
Country: Spain
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in BCN Checkpoint
lock Showing 1 of 2 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Evaluation of Dasatinib Safety and Tolerability in Asymptomatic Patients with Recent HIV-1 Infection: A Pilot Clinical Trial | Fundacio De Recerca Clinic Barcelona-Institut D’Investigacions Biomediques August Pi I Sunyer | Phase II | Not Recruiting | Jan 2026 | — |
IMP list
lock Showing 1 of 4 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Cabotegravir | 1 | Unknown | 2023-10-05 | 2023-10-05 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.